Chronic Wound Infection Drug Therapy Hope
- Here's a breakdown of the key information from the provided text, focusing on the research and its potential impact:
- * Chronic Wounds & Infection: Chronic wounds (like diabetic foot ulcers) are difficult to heal, often due to infection by bacteria like Pseudomonas aeruginosa.
- * Chlorate & Antibiotic Synergy: Combining small doses of chlorate with standard antibiotics dramatically increases their effectiveness - 10,000 times more potent in lab tests.
Here’s a breakdown of the key information from the provided text, focusing on the research and its potential impact:
The Problem:
* Chronic Wounds & Infection: Chronic wounds (like diabetic foot ulcers) are difficult to heal, often due to infection by bacteria like Pseudomonas aeruginosa.
* Antibiotic Resistance/Tolerance: P. aeruginosa becomes tolerant to antibiotics in the low-oxygen habitat of chronic wounds. Standard antibiotic testing is done in oxygen-rich conditions and focuses on fast-growing bacteria, making these antibiotics ineffective against the slow-growing bacteria in wounds.
* Diabetic Foot Ulcers: A meaningful problem – 1 in 4 people with Type 2 diabetes develop foot ulcers, and over half become infected, sometimes leading to amputation.
The Solution:
* Chlorate & Antibiotic Synergy: Combining small doses of chlorate with standard antibiotics dramatically increases their effectiveness – 10,000 times more potent in lab tests.
* Mechanism: Chlorate “stresses the bacterial cell” making it more vulnerable to the antibiotics. In low-oxygen conditions, bacteria switch to nitrate respiration. Chlorate interferes with this process.
* Reduced Dosage: The increased potency allows for lower doses of antibiotics, possibly reducing toxicity.
Potential Benefits:
* Shorter Treatment Times: Could reduce the duration patients need to take antibiotics.
* Lower Toxicity: Lower antibiotic doses mean less risk of side effects.
* Combating Antibiotic Resistance: This strategy could be a broader approach to fighting antibiotic resistance by finding synergistic combinations of existing drugs.
* Improved Wound Healing: By effectively tackling the infection, it could promote wound closure and reduce the need for amputation.
Research Details:
* researcher: Melanie Spero (University of Oregon)
* Funding: $1.84 million grant from the National Institutes of Health.
* Previous Work: Spero’s earlier research at Caltech showed similar results in cell cultures and diabetic mouse models.
Key Quote:
“I think that drug combinations will be a critical approach that helps us fight against the rise of antibiotic resistance.Finding examples of synergy among antimicrobials that are already on the market is going to be really valuable. And we’ll need to dig further into the mechanisms behind why they work well together.” – Melanie Spero.